West nile virus infection and myasthenia gravis

Muscle Nerve. 2014 Jan;49(1):26-9. doi: 10.1002/mus.23869. Epub 2013 Sep 11.

Abstract

Introduction: Viruses are commonly cited as triggers for autoimmune disease. It is unclear if West Nile virus (WNV) initiates autoimmunity.

Methods: We describe 6 cases of myasthenia gravis (MG) that developed several months after WNV infection. All patients had serologically confirmed WNV neuroinvasive disease. None had evidence of MG before WNV.

Results: All patients had stable neurological deficits when they developed new symptoms of MG 3 to 7 months after WNV infection. However, residual deficits from WNV confounded or delayed MG diagnosis. All patients had elevated acetylcholine receptor (AChR) antibodies, and 1 had thymoma. Treatment varied, but 4 patients required acetylcholinesterase inhibitors, multiple immunosuppressive drugs, and intravenous immune globulin or plasmapheresis for recurrent MG crises.

Conclusions: The pathogenic mechanism of MG following WNV remains uncertain. We hypothesize that WNV-triggered autoimmunity breaks immunological self-tolerance to initiate MG, possibly through molecular mimicry between virus antigens and AChR subunits or other autoimmune mechanisms.

Keywords: West Nile virus; autoimmunity; molecular mimicry; myasthenia gravis; neuromuscular junction; poliomyelitis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antibodies / blood
  • Cholinesterase Inhibitors / therapeutic use
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Myasthenia Gravis / immunology*
  • Myasthenia Gravis / therapy
  • Myasthenia Gravis / virology*
  • Plasmapheresis
  • Receptors, Cholinergic / immunology
  • Retrospective Studies
  • Self Tolerance / immunology
  • West Nile Fever / complications*
  • West Nile Fever / immunology*
  • West Nile Fever / therapy
  • West Nile virus*

Substances

  • Antibodies
  • Cholinesterase Inhibitors
  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Receptors, Cholinergic